Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

METLIFE INC Director's Dealing 2017

Sep 15, 2017

29995_dirs_2017-09-15_23a36e64-08db-4aa5-bb97-0404de107bee.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2017-09-13

Reporting Person: HUBBARD ROBERT GLENN (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-09-13 Common Stock A 315.1069 $48.65 Acquired 46417.9924 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-08-07 Common Stock Equivalents $ A 1844.9973 Acquired Common Stock (1844.9973) Direct
2017-09-13 Common Stock Equivalents $ A 142.2508 Acquired Common Stock (142.2508) Direct

Footnotes

F1: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

F2: Includes 4,086.9453 Deferred Shares previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Deferred Shares in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Deferred Shares.

F3: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F4: Represents imputed reinvestment of dividends on Common Stock Equivalent Units.

F5: Common Stock Equivalents previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Common Stock Equivalents in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Common Stock Equivalents.